[Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Int J Oncol. 2022 Jul;61(1):86. doi: 10.3892/ijo.2022.5376. Epub 2022 Jun 1.
Int J Oncol. 2022.
PMID: 35642668
Free PMC article.